FITC anti-human CD8 Antibody by BioLegend
Sample/Target/Tissue: PBMC of leukemia patients "The T cells can be clearly identified, no unclaer results, very good antibody. It is good to titrate, since less material may be used." Review date: 28 May 2021 | FITC anti-human CD8
Source: selectscience.net